BeStock  

Repligen RGEN

US equityMarket cap rank #1375Medical Instruments & Supplies
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership118.3%-5.26 pts vs. prior quarter
Institutions holding607+40 vs. prior quarter
Insider trades (recent)30 buys / 20 sellsNet buying
Short interest11.11% of floatDays to cover 4.9 · as of 30 Oct 2026
Short-sale volume share16.9%5-day average of daily volume

Short-sale volume as % of daily volume

10%18%25%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$3.55M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$69.4KSuper+$3.6MBig−$940.9KMid−$1.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 34.0% of shares outstanding.

Largest holders

  • FMR11.50%
  • BlackRock8.96%
  • T. Rowe Price Group, Inc.4.95%
  • United Capital Financial Advisors4.37%
  • Roy T Eddleman Living Trust Uad 08/17/20004.23%
  • Vanguard Capital Management, LLC3.82%
  • Vanguard Portfolio Management, LLC3.55%
  • Maverick Capital, Ltd.3.10%

By investor type

  • Mutual Fund93.86%
  • Hedge Fund11.99%
  • Private Company5.01%
  • Public Company3.86%
  • Government Pension Fund1.47%
  • Sovereign Wealth Fund0.90%
  • VC/PE Fund0.40%
  • Family Office/Trust0.30%

Reported short interest has risen from 10.78% to 11.11% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +4,024,155 11.5%
Capital Research Mutual Fund 2026/Q3 +718,151 1.1%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +642,200 2.3%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +342,266 0.5%
BlackRock Mutual Fund 2026/Q3 +341,793 9.0%
Artemis Investment Management LLP Mutual Fund 2026/Q3 +252,755 0.6%
UBS Asset Management Mutual Fund 2026/Q3 +208,384 1.8%
Barclays PLC Public Company 2026/Q3 +199,807 0.6%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +808,202 1.4%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +650,918 2.5%
Holocene Advisors, LP Hedge Fund 2026/Q3 +583,302 2.0%
Maverick Capital, Ltd. Hedge Fund 2026/Q3 +465,749 3.1%
FMR Mutual Fund 2026/Q3 +439,993 5.9%
Janus Henderson Group plc Mutual Fund 2026/Q3 +381,685 0.6%
Wasatch Advisors LP Mutual Fund 2026/Q3 +346,720 2.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Oct 2026 Brian Douglass Senior VP & Chief Product Officer Other Acquisition +700 – 7,077
5 Oct 2026 Brian Douglass Senior VP & Chief Product Officer Other Derivative Acquisition +675 $174.86 675
4 Oct 2026 Olivier Loeillot Chief Executive Officer Open Market Disposition -1,333 $178.75 1
4 Oct 2026 Olivier Loeillot President & Chief Commercial Officer Intent to Sell (Form 144) -4,202 $190.00 –
4 Oct 2026 Olivier Loeillot President & Chief Commercial Officer Intent to Sell (Form 144) -1,333 $178.75 –
4 Oct 2026 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -4,202 $190.00 1
1 Oct 2026 Olivier Loeillot Chief Executive Officer Sale to Issuer -1,248 $181.70 1,334
24 Sep 2026 Jason Garland CFO & Chief Compliance Officer Sale to Issuer -421 $189.68 3,319
23 Sep 2026 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -12,946 $190.00 1
20 Sep 2026 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -5,426 $180.00 1
3 Sep 2026 Olivier Loeillot Chief Executive Officer Automatic Disposition -3,035 $165.90 1
2 Sep 2026 Olivier Loeillot Chief Executive Officer Sale to Issuer -2,842 $169.61 1
31 Aug 2026 Violetta Hughes Chief Accounting Officer Sale to Issuer -277 $170.02 551
19 Aug 2026 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -5,426 $180.00 1
15 Jul 2026 Jason Garland CFO & Chief Compliance Officer Automatic Disposition -530 $150.00 2,640
24 Jun 2026 Jason Garland CFO & Chief Compliance Officer Automatic Disposition -733 $145.00 3,170
13 May 2026 Glenn Muir Independent Director Other Acquisition +995 – 995
13 May 2026 Glenn Muir Independent Director Other Derivative Acquisition +2,239 $103.38 2,239
13 May 2026 Martin Madaus Independent Chairperson Other Acquisition +995 – 995
13 May 2026 Martin Madaus Independent Chairperson Other Derivative Acquisition +2,239 $103.38 2,239

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,054,160 11.1% 4.9
15 Oct 2026 7,145,036 11.3% 4.9
30 Sep 2026 7,581,634 13.4% 6.6
15 Sep 2026 6,712,693 11.9% 7.1
31 Aug 2026 6,612,877 11.7% 6.7
14 Aug 2026 6,085,313 10.8% 6.4

Discussion

No comments yet — be the first to weigh in on RGEN.

Sign in to join the discussion.

Scroll to Top